This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Data availability
Data used in this manuscript is available to readers promptly upon request.
References
Britton PN, Dale RC, Blyth CC, Clark JE, Crawford N, Marshall H, et al. Causes and clinical features of childhood encephalitis: a multicenter, prospective cohort study. Clin Infect Dis. 2020;70:2517–26.
Sarma A, Hanzlik E, Krishnasarma R, Pagano L, Pruthi S. Human parechovirus meningoencephalitis: neuroimaging in the era of polymerase chain reaction-based testing. AJNR Am J Neuroradiol. 2019;40:1418–21.
Network CHA. Recent Reports of Human Parechovirus (PeV) in the United States—2022. 2022. Available from: https://emergency.cdc.gov/han/2022/han00469.asp.
van Zwol AL, Lequin M, Aarts-Tesselaar C, van der Eijk AA, Driessen GA, de Hoog M, et al. Fatal neonatal parechovirus encephalitis. BMJ Case Rep. 2009:2009:bcr05.2009.1883.
Ibrahim J, Mir I, Chalak L. Brain imaging in preterm infants < 32 weeks gestation: a clinical review and algorithm for the use of cranial ultrasound and qualitative brain MRI. Pediatr Res. 2018;84:799–806.
Iro MA, Martin NG, Absoud M, Pollard AJ. Intravenous immunoglobulin for the treatment of childhood encephalitis. Cochrane Database Syst Rev. 2017;10:CD011367.
Westerhuis BM, Koen G, Wildenbeest JG, Pajkrt D, de Jong MD, Benschop KSM, et al. Specific cell tropism and neutralization of human parechovirus types 1 and 3: implications for pathogenesis and therapy development. J Gen Virol. 2012;93:2363–70.
Acknowledgements
We thank the NeuroNICU team at UT Southwestern for the amazing work with diagnosis and treatment of infants with HPeV infection. We thank Pollieanna Sepulveda in particular for assistance with database and meeting coordination between teams.
Author information
Authors and Affiliations
Contributions
MSO conceptualized and designed the study, conducted the formal data analyses, drafted the initial manuscript, and critically reviewed and revised the manuscript. DA conceptualized and designed the study, and reviewed and revised the manuscript. RC performed imaging analyses, and reviewed and revised the manuscript. LC, MP, JT, MM, and AD were responsible for the concept, analysis, and interpretation of data, and revising the manuscript. All authors approved the final manuscript as submitted.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval and consent to participate
This study was approved by the University of Texas Southwestern Institutional Review Board, and informed parental consent was waived per IRB guidelines.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Oren, M.S., Clarke, R.L., Price, M. et al. Human Parechovirus (HPeV) infections: clinical presentations, patterns, and evolution of neonatal brain injury. J Perinatol 44, 581–583 (2024). https://doi.org/10.1038/s41372-023-01851-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41372-023-01851-w